NB
NovaBridge Biosciences
NBP · NASDAQ
$1.61 -1.23% (-$0.02)
1M -14.81%
Market Cap $90.2M
P/E Ratio -
Div. Yield -
ROE 0.59%
Piotroski F-Score Weak
1/9Valuation
71 /100
Cheap P/B 2.73x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 94.82%
ROE 0.59%
ROA 53.39%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 8.09x
Int. coverage N/A
Stability
33 /100
Unstable Beta 1.50x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre NBP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Srishti Gupta
Employees
30
Headquarters
Rockville
Evenimente viitoare
12 NOV.
Earnings
Upcoming earnings report
31 MAR.
Earnings
Upcoming earnings report